Antiangiogenic therapy for breast cancer

Pablo M. Bedano, Bryan Schneider, Kathy Miller, George W. Sledge

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Angiogenesis plays a central role in both local tumor growth as well as distant metastasis in breast cancer (1). The inhibition of angiogenesis is an attractive therapeutic target, with the potential for widespread activity and low toxicity, as well as the potential for synergy with classic cytotoxic therapy and radiotherapy. In this chapter, we explore the role of angiogenesis in breast cancer and recent attempts to quantify angiogenesis and tumor vasculature. We also discuss clinical trial results, potential mechanisms of resistance, and the special challenges posed by the development of antiangiogenic agents.

Original languageEnglish (US)
Title of host publicationAntiangiogenic Cancer Therapy
PublisherCRC Press
Pages559-586
Number of pages28
ISBN (Electronic)9781420004298
ISBN (Print)9780849327995
DOIs
StatePublished - Jan 1 2007

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Antiangiogenic therapy for breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Bedano, P. M., Schneider, B., Miller, K., & Sledge, G. W. (2007). Antiangiogenic therapy for breast cancer. In Antiangiogenic Cancer Therapy (pp. 559-586). CRC Press. https://doi.org/10.1201/9781420004298